-
Signature
-
/s /Bart E. Volkmer, Attorney-in-Fact
-
Stock symbol
-
DBX
-
Transactions as of
-
Dec 11, 2024
-
Transactions value $
-
-$4,132,230
-
Form type
-
4
-
Date filed
-
12/13/2024, 05:46 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
DBX |
Class A Common Stock |
Conversion of derivative security |
$0 |
+137K |
|
$0.00 |
137K |
Dec 11, 2024 |
See Footnote |
F1, F2 |
transaction |
DBX |
Class A Common Stock |
Sale |
-$4.13M |
-137K |
-100% |
$30.05 |
0 |
Dec 11, 2024 |
See Footnote |
F2, F3, F4 |
holding |
DBX |
Class A Common Stock |
|
|
|
|
|
444K |
Dec 11, 2024 |
See Footnote |
F5 |
holding |
DBX |
Class A Common Stock |
|
|
|
|
|
8.27M |
Dec 11, 2024 |
Direct |
F6 |
holding |
DBX |
Class A Common Stock |
|
|
|
|
|
717K |
Dec 11, 2024 |
See Footnote |
F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
DBX |
Class B Common Stock |
Conversion of derivative security |
$0 |
-137K |
-0.2% |
$0.00 |
68.4M |
Dec 11, 2024 |
Class A Common Stock |
137K |
|
See foonote |
F2, F8 |
holding |
DBX |
Class B Common Stock |
|
|
|
|
|
7.74M |
Dec 11, 2024 |
Class A Common Stock |
7.74M |
|
See footnote |
F7, F8 |
holding |
DBX |
Class B Common Stock |
|
|
|
|
|
501K |
Dec 11, 2024 |
Class A Common Stock |
501K |
|
See footnote |
F8, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: